# ArteryFlow Technology Co., Ltd.

- Location (FDA's records): Hangzhou City, CN
- FDA decisions: 6 (2021–2023): 6 510(k) clearances
- Product codes: QHA (3), LLZ (2), PZO (1)
- Predicates its devices cite: 6 (3 its own); citations of its devices by later devices: 3 (3 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Medis Medical Imaging Systems BV: 1 (https://510kreport.com/company/medis-medical-imaging-systems)
- Ischemaview, Inc.: 1 (https://510kreport.com/company/ischemaview)
- Sim&Cure: 1 (https://510kreport.com/company/sim-cure)

## Its most-cited devices
- K210093: AccuFFRangio (2021), cited by 2
- K220663: AccuCTP (2022), cited by 1

## Recent decisions
- K231353: AccuCTP Pro (Sep 14, 2023)
- K230303: AccuFFRangio Plus (Mar 2, 2023)
- K221711: AccuICAS (Feb 28, 2023)
- K220663: AccuCTP (Nov 22, 2022)
- K213838: AneuGuide (Jun 1, 2022)
- K210093: AccuFFRangio (Sep 10, 2021)

Source page: https://510kreport.com/company/arteryflow-technology